Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18816526 | MULTI-MODAL PRESSURE SENSOR | August 2024 | March 2025 | Allow | 7 | 2 | 1 | No | No |
| 18541217 | SYSTEM FOR CONCUSSION ASSESSMENT | December 2023 | December 2024 | Abandon | 12 | 1 | 0 | No | No |
| 18385294 | SYSTEM AND METHOD OF ASSESSING INTRA-ARTERIAL FLUID VOLUME USING INTELLIGENT PULSE AVERAGING WITH INTEGRATED EKG AND PPG SENSORS | October 2023 | November 2024 | Allow | 13 | 2 | 0 | No | No |
| 18300745 | MULTI-MODAL PRESSURE SENSOR | April 2023 | July 2024 | Allow | 16 | 4 | 0 | No | No |
| 17874764 | ELECTRIC PULSE MASSAGE APPARATUS AND SYSTEM | July 2022 | April 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17856208 | CARDIOVASCULAR DETECTION SYSTEM AND METHOD | July 2022 | May 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17829449 | SYSTEMS AND METHODS UTILIZING PHASE-BASED BIOMARKER IN THE BRAIN | June 2022 | March 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17514393 | WEARABLE DEVICE AND METHOD OF GENERATING SIGNAL FOR CONTROLLING OPERATION OF ELECTRONIC DEVICE | October 2021 | June 2025 | Abandon | 43 | 2 | 0 | No | No |
| 17601378 | DIAGNOSIS | October 2021 | May 2024 | Abandon | 32 | 1 | 1 | No | No |
| 17300719 | Method And Assembly For Predicting The Occurrence Of Heart Disease Within An Individual | October 2021 | September 2024 | Abandon | 36 | 2 | 0 | Yes | No |
| 17438597 | MEASUREMENT METHOD AND APPARATUS FOR PERIOD INFORMATION OF BIOLOGICAL SIGNAL, AND ELECTRONIC DEVICE | September 2021 | April 2025 | Abandon | 43 | 4 | 0 | No | No |
| 17405479 | USER AWARE MICROCURRENT THERAPY DEVICE | August 2021 | June 2025 | Allow | 46 | 3 | 1 | Yes | No |
| 17392033 | STROKE DETECTION AND MITIGATION | August 2021 | December 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17384912 | Smart Wearable Device | July 2021 | January 2025 | Abandon | 41 | 2 | 1 | No | No |
| 17417892 | SYSTEM AND METHOD FOR MEASURING AND MANAGING SLEEP EFFICACY IN A NON-INVASIVE MANNER | June 2021 | September 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17354811 | AUTOREGULATION MONITORING USING DEEP LEARNING | June 2021 | April 2025 | Abandon | 45 | 4 | 0 | Yes | No |
| 17353793 | SYSTEM, METHOD, AND HEAD MOUNTED DISPLAY FOR CONSUSSION ASSESSMENT | June 2021 | February 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17308676 | METHOD AND DEVICE TO DETERMINE SLEEP APNEA OF A USER | May 2021 | May 2024 | Abandon | 36 | 2 | 0 | Yes | No |
| 17229759 | System and Method of Measuring Venous Oxygen Saturation Using Intelligent Pulse Averaging With Integrated EKG and PPG Sensors | April 2021 | November 2023 | Allow | 31 | 2 | 0 | Yes | No |
| 17284035 | A PREDICTIVE DIAGNOSTIC SYSTEM FOR A DISTRIBUTED POPULATION OF AUTOMATED EXTERNAL DEFIBRILLATOR DEVICES | April 2021 | February 2025 | Allow | 47 | 2 | 0 | Yes | Yes |
| 17222863 | WEARABLE FOOTWEAR SENSOR ARRAYS FOR DETECTION OF CARDIAC EVENTS, BODY MOTION, AND MUSCULAR ACTIONS | April 2021 | March 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17222591 | Biometric Mood Sensing Apparatus and Method of Use | April 2021 | May 2024 | Abandon | 38 | 1 | 1 | No | No |
| 17217200 | IMPLANTABLE CAPSULE AND GASTROESOPHAGEAL REFLUX DISEASE DETERMINING SYSTEM THEREOF | March 2021 | November 2024 | Abandon | 43 | 3 | 0 | No | No |
| 17181199 | MOBILE APPLICATION TO PROMPT PHYSICAL ACTION TO MEASURE PHYSIOLOGIC RESPONSE IN IMPLANTABLE DEVICE | February 2021 | November 2024 | Abandon | 45 | 2 | 0 | Yes | No |
| 17263709 | MOBILE DIAGNOSTIC SYSTEM FOR THE EARLY DETECTION OF VASCULAR DISEASES | January 2021 | November 2024 | Abandon | 46 | 2 | 0 | No | No |
| 17154112 | METHOD AND APPARATUS FOR MEASURING ROBUST PULSE RATE AND RESPIRATORY RATE USING FACIAL IMAGES | January 2021 | April 2025 | Abandon | 51 | 6 | 0 | Yes | No |
| 17147561 | Electronic Skin | January 2021 | March 2024 | Abandon | 38 | 2 | 0 | No | No |
| 17140545 | TECHNOLOGIES FOR DETERMINING A CONDITION OF A PATIENT USING LC RESONATOR DATA | January 2021 | March 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17136150 | APPARATUS AND METHOD FOR ESTIMATING BIO-INFORMATION | December 2020 | July 2024 | Allow | 43 | 4 | 1 | Yes | No |
| 17255916 | IMPLANTABLE NEURAL STIMULATION DEVICE WITH TWO HEADERS | December 2020 | April 2025 | Abandon | 52 | 5 | 0 | Yes | No |
| 17115864 | SYSTEM AND METHOD FOR DETECTING HOT FLASHES BASED ON HEART RATE PATTERNS | December 2020 | September 2024 | Abandon | 45 | 4 | 0 | No | No |
| 17053425 | SYSTEM FOR MONITORING AND PROVIDING ALERTS OF A FALL RISK BY PREDICTING RISK OF EXPERIENCING SYMPTOMS RELATED TO ABNORMAL BLOOD PRESSURE(S) AND/OR HEART RATE | November 2020 | November 2024 | Abandon | 48 | 2 | 0 | Yes | No |
| 17072145 | SYSTEMS AND METHODS FOR THE DETERMINATION OF AROUSAL STATES, CALIBRATED COMMUNICATION SIGNALS AND MONITORING AROUSAL STATES | October 2020 | March 2025 | Abandon | 53 | 2 | 1 | Yes | No |
| 17033358 | SYSTEM AND METHOD TO PREDICT A STATE OF DROWSINESS IN A SUBJECT | September 2020 | July 2024 | Abandon | 45 | 2 | 0 | No | No |
| 17029295 | HEART RHYTHM PROCESSING METHOD, ELECTRONIC DEVICE, AND COMPUTER PROGRAM | September 2020 | December 2024 | Abandon | 51 | 5 | 0 | Yes | No |
| 17006971 | HEART RATE VARIABILITY NOTIFICATION DEVICE | August 2020 | April 2024 | Abandon | 44 | 3 | 1 | No | No |
| 16943046 | SYSTEM AND METHOD OF PHOTOPLETHYSMOGRAPHY BASED HEART-RATE ESTIMATION IN PRESENCE OF MOTION ARTIFACTS | July 2020 | March 2024 | Abandon | 44 | 4 | 0 | Yes | No |
| 16921757 | STABILIZING ACCESSORY FOR ADHESIVE MEDICAL DEVICES | July 2020 | March 2025 | Abandon | 57 | 4 | 1 | No | No |
| 16858252 | CATHETER INCLUDING ONE OR MORE SENSORS | April 2020 | November 2024 | Abandon | 54 | 4 | 2 | Yes | No |
| 16579763 | SURGICAL SYSTEM AND METHOD OF DISPLAYING INFORMATION IN THE SAME | September 2019 | November 2024 | Abandon | 60 | 5 | 0 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HADDAD, MOUSSA MAHER.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner HADDAD, MOUSSA MAHER works in Art Unit 3796 and has examined 39 patent applications in our dataset. With an allowance rate of 15.4%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.
Examiner HADDAD, MOUSSA MAHER's allowance rate of 15.4% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HADDAD, MOUSSA MAHER receive 2.51 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HADDAD, MOUSSA MAHER is 43 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +18.3% benefit to allowance rate for applications examined by HADDAD, MOUSSA MAHER. This interview benefit is in the 64% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 7.7% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 14.3% of cases where such amendments are filed. This entry rate is in the 9% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 6% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.